We are monitoring the impact of COVID-19 on APAC Thyroid cancer Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2170
Share on
Share on

Asia Pacific Thyroid Cancer Market Research Report – Segmented By Treatment, End User, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: February, 2020
ID: 2170
Pages: 140

APAC Thyroid Cancer Market Size & Growth (2019-2024)

As per our report, Thyroid Cancer Market in the Asia Pacific was valued at USD 46.38 million in 2019 and is expected to grow at a CAGR of 30.16% to reach USD 173.26 million by 2024 from 2019 to 2024.

Thyroid cancer is basically treated by surgery and radiotherapy. Chemotherapy has fewer roles in the treatment. Doxorubicin is said to be used as an off-label drug for treating plastic thyroid cancer patients. In the same way some other off-name medications, for example, carboplatin and cisplatin are used, however response rates have come down because of them. It can be concluded that Asia Pacific Thyroid Cancer Market is expected to have a high growth rate.

Asia Pacific Thyroid Cancer Market is strong because it consists of 27 molecules that are in different stages of development. There are four molecules in Pre-registration (1) and Phase III (3). These drugs mostly get approved in the next 7 years.  XL184, Zactima, and Zybrestat have been granted orphan drug status by the FDA.

Once the above molecules get approved, it will intensify competition in the market which in turn results in substantial growth in market. Current competition in Asia Pacific Thyroid Cancer Market is very less. Some effective treatments like surgery exist and chemotherapy drugs can be used. Companies such as Doxorubicin which aim at managing conditions are prone to get larger success in the future.

APAC Thyroid Cancer Market segmented and sub-segmented into the following categories.

  • By Treatment: Surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs.
  • By Drug: Levothyroxine and Radioiodine
  • By End User: Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Noteworthy players dominating the APAC Thyroid Cancer Market profiled in this report are Baxter International Inc., Mylan pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co, Abbott laboratories, Teva parenteral medicines Inc., App pharmaceuticals LLC and Jerome Stevens Pharmaceuticals Inc.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Treatment                                                  

                                5.1.1 Introduction                                           

                                5.1.2 Surgery                                     

                                5.1.3 Iodine Theraphy                                   

                                5.1.4 External radiotherapy                                        

                                5.1.5 Thyroxine treatment                                          

                                5.1.6  chemotherapy                                     

                                5.1.7 Drugs                                         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.9  Market Attractiveness Analysis, By Treatment                                       

                                5.1.10 Market Share Analysis, By Treatment                                       

                5.2 End User      

                                5.2.1 Introduction                                           

                                5.2.2 Hospital                                    

                                5.2.3 Oncology centers                                 

                                5.2.4 Hospital Pharmacies                                            

                                5.2.5 Retail Pharmacies                                 

                                5.2.6 Y-o-Y Growth Analysis, By End User                                             

                                5.2.7 Market Attractiveness Analysis, By End User                                           

                                5.2.8 Market Share Analysis, By End User                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Treatment                     

                                                6.1.3.3 By End User                        

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Treatment                     

                                                6.1.4.3 By End User                        

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Treatment                     

                                                6.1.5.3 By End User                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Baxter International Inc                                                        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Mylan pharmaceuticals Inc                                                  

                8.3 Alara Pharmaceutical Corporation                                                    

                8.4  Bristol Myers co                                                       

                8.5  Abbott laboratories                                                               

                8.6 Teva parenteral medicines Inc                                                           

                8.7 App pharmaceuticals llc                                                         

                8.8  Jerome Stevens Pharmaceuticals Inc                                                             

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  2. Asia Pacific Surgery Market By Region, From 2019-2024 ( USD Million )
  3. Asia Pacific Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  4. Asia Pacific External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  5. Asia Pacific Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  6. Asia Pacific chemotherapy Market By Region, From 2019-2024 ( USD Million )
  7. Asia Pacific Drugs Market By Region, From 2019-2024 ( USD Million )
  8. Asia Pacific Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  9. Asia Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  10. Asia Pacific Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  11. Asia Pacific Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  12. Asia Pacific Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  13. Japan Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  14. Japan Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  15. China Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  16. China Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  17. India Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  18. India Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  19. Australia Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  20. Australia Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  21. South Korea Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  22. South Korea Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample